Best Life Sciences Companies in Brazil
The 166 best Life Sciences companies in Brazil in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: SouSmile.
Brazil's Life Sciences sector is moving fast, and this directory ranks 166 companies operating across it by disclosed equity funding and recent momentum. Total disclosed funding sits at $45M, with SouSmile leading the pack at $15M, Hilab close behind at $10M, and Open Health at $3M. No unicorns yet, but the trajectory's real. Globally, the life sciences market was pegged at $167.8B with a 10.2% CAGR, driven by aging populations and accelerating institutional funding. So what does that mean for Brazil specifically? It means the gap between global scale and local disclosed capital is also an opportunity map.
The investor side tells you something too. KPTL, Vesper Ventures, Biominas, Crescera Capital, and Criatec 2 are the most active backers in this cohort, which I'd read as a signal that early-stage Brazilian life sciences still runs on specialist conviction rather than generalist appetite. Median app install growth across health and life sciences apps hit +43% YoY, and moves like Asahi Songwon's API acquisition and SAI Life Sciences' IPO push show global players actively consolidating and scaling. Brazil's funding base is still thin, but digital health adoption is compressing the timeline.
- Morgan Stanley Ups the Ante on These 2 Life Science Tool Stocks
Our analysis of 576 Life Sciences companies
$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Brazil
| # | Company | Last round | Disclosed funding | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2i Manufacture of healthcare products intended to focus on infection prevention and disinfection control… | — | — | Private | 26 | — | Wix eCommerceWixSentry+12 | — | — |
| 2 | 3DBS Provider of bioprinting technology and services for tissue engineering and personalized medicine | — | — | Unfunded | — | Pedro Massaguer CEO | WordPressMySQLPHP+18 | — | 1 job opening · 1 internship · 1 partnership |
| 3 | Actiz Laboratory information management system for the healthcare industry | — | — | Unfunded | 16 | Ramon Valentina Co-Founder & CEO | WordPress Block EditorWordPressMySQL+26 | — | — |
| 4 | Aeskins Manufacturer of derma fillers and injections for aesthetic procedures | — | — | Acquired | — | Monica M Branco Ferreira CEO | — | — | — |
| 5 | Alben (Healthcare Technology Systems) Developer of sterilizing technology intended to make access to protection a simple and efficient way. | — | — | Private | 11 | — | — | — | — |
| 6 | ALJAVA BIOTECH Provider of technology for precision cancer therapy development | — | — | Funding Raised | — | James Goss Co-Founder | — | — | — |
| 7 | Alliage Global Manufacturer of equipment and solutions for the medical and dental segments | — | — | Unfunded | — | — | WordPressMySQLPHP+22 | — | — |
| 8 | Alpha Reagents Manufactures laboratory equipment and labware | — | — | Deadpooled | — | Mayko Batalha Salvador Founder | — | — | — |
Top 12 Life Sciences companies in Brazil
#1
Seed · Sao Paulo, State of Sao Paulo · founded 2022$3Mraised▾
AI-powered platform to analyse laboratory results. It offer software for laboratories, nutritionists, and doctors that integrates and analyses all different types of laboratory exams and structures the data into a harmonized standard.
- Sep 2025Seed$3M
#2
Seed · Florianopolis, State of Santa Catarina · founded 2023$93.9Kraised▾
Developer of personalized myoelectric prosthetics and three-dimensional printed prosthetic components. The company provides upper limb prosthetics designed to restore mobility. These devices aim to improve autonomy, comfort, and overall quality of life for individuals with limb differences.
- Oct 2025Seed$93.9K
#3
Series B · Curitiba, Parana · founded 2004 · 217 employees$10Mraised▾
Developed remote monitoring system and devices. The company offers AI-based remote diagnostics and testing services for employees and individuals. The company offers health test services which are done through miniature laboratory devices that employ AI-powered technology. The company provides tests for COVID, and any other antigen testing.
- Nov 2022Series B—
- Nov 2020Series B$10M
- Dec 2018Grant (prize money)—
#4
Series B · Paulista, Pernambuco · founded 2018 · 192 employees$14.9Mraised▾
Provider of invisible aligner treatments for individuals to improve the smile. It offers UltraSmile technology that takes teeth 3D scan, x rays, and pictures which are used to diagnose and create customized braces along with non sensitive whitening gel.
- Oct 2021Series B$18M
- Mar 2020Series A$10M
- Oct 2019Series A$4.9M
#5
Seed · Sao Paulo, State of Sao Paulo · founded 2021$1.9Mraised▾
Provider of gene bio-bank services to accelerate precision medicines. It offers a platform for genetic biobank for genomic researcha to accelerate precision medicine and the development of medicines.
- Oct 2023Seed—
- Sep 2022Seed$1.9M
#6
Seed · Manaus, Amazonas · founded 2020$481Kraised▾
Provider of logistics system for pharmaceutical wholesalers. The company offer solutions for monitoring medications, integrating proprietary and third-party hardware with software that includes dashboards and artificial intelligence.
- May 2024Seed$481K
- 2020Seed—
#7
Series A · Rio de Janeiro, State of Rio de Janeiro · founded 2015 · 9 employees$7Mraised▾
GlobalYeast produces and supplies yeast-based fermentation additives. It provides industrial yeast strains and industrial fermentation services for first-generation bioethanol, second-generation bioethanol and biobased chemicals from renewable resources. The company has developed a solution called biocal for monitoring of sugar conversion to ethanol and also helps in designing strategies for process optimization and also offers tailored yeast strains for optimization of E1G production or for converting C5 sugar streams.
- May 2015Series A$7M
#8
Series A · Sao Paulo, Sao Paulo · founded 2006$3.4Mraised▾
ReceptaBio is developing monoclonal antibodies & peptides for cancer treatments. The company has a portfolio of monoclonal antibodies which are in clinical stages. The lead molecule, RebmAb100 is a humanized monoclonal antibody which targets Y antigen of the Lewis blood group (LeY). The company has conducted Phase II clinical trials for this molecule in Brazil in patients with ovarian and breast tumors. Other antibodies are RebmAb700 ( blocked PD-1) & RebmAb600 (blocks the antigen 4 associated with the cytotoxic T lymphocyte,CTLA-4), RebmAb200 (targets NaPi2b). The peptide portfolio includes Rb9 and Rb10, generated from the complementarity determining regions of humanized monoclonal antibodies.
- Jul 2012Series A$3.4M
#9
Seed · Sao Paulo, State of Sao Paulo · founded 2019 · 45 employees$553.8Kraised▾
Developer of nutritional products for the prevention and modulation of chronic diseases. The company focuses on the development of bioactive natural extracts that prevent and delay the aging process. The company's first product is a Phyto complex natural extract that acts on the musculoskeletal system to prevent and modulate major health problems such as osteopenia and osteoporosis, arthritis and arthrosis, myalgia, sarcopenia, and bone fragility, among others.
- Jul 2022Seed$553.8K
#10
Seed · Florianopolis, State of Santa Catarina · founded 2010 · 66 employees$1.8Mraised▾
Neoprospecta develops microbial analyses methods using NGS, bioinformatics, and qPCR for a variety of application areas. It offers services for infectious disease surveillance and diagnosis, monitoring of disease resistance, contamination tracking and containment in food packaging, hospitals, and animal health. The company also offers sequencing services on the Illumina platform, bespoke bioinformatics services, and microbiological analyses. The Digital Microbiological Diagnosis service that includes DMD Microbiome (for identification and quantification of fungi, bacteria, and protozoa), DMD Resistoma (for identification of genes conferring resistance to antibiotics), and others.
- Sep 2014Seed$1.8M
#11
Seed · Campinas, Sao Paulo · founded 2017 · 5 employees$1.2Mraised▾
SpecLab is a developer of analytical solutions and equipment. The products offered are OEM NIR (spectrometer integrated with computer, autosampler and chemometric models) which are SpecScan (VIS-NIR spectrometer for large flow), SpecScan L (Portable spectrometer for liquid analysis), and SpecScan R (Portable solids spectrometer). The SpecLab Analytics Platform that collects the data from the equipment to analyze and provide results.
- Jun 2018Seed$1.2M
#12
Seed · Sao Paulo, State of Sao Paulo · founded 2013 · 7 employees$250Kraised▾
Developer of cell therapies for heart and neurological problems. It offers cardiac-cell-based therapeutics for Heart Failure and astrocytes-based therapeutics for Rett Syndrome.
- Jul 2022Seed$250K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Brazil
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,470 Brazil-affiliated papers.
- Universidade de São Paulo120
- Universidade Estadual de Campinas113
- Universidade Estadual Paulista85
- Ministry of Education70
- Brazilian Agricultural Research Corporation64
- Gene9
- Genome7
- Metabolomics7
- Production (economics)6
- Livestock5
- Context (archaeology)2→47
- Fermentation2→36
- Antimicrobial3→34
- Bacteria1→17
- Biomass (ecology)1→17
- Biofuel1→5
- Fermentation1→5
- In vitro1→4
Where biotechnology is researched across Brazil
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.